These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9824933

  • 1. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
    Briceño Delgado FJ, López Cillero P, Rufián Peña S, Solórzano Peck G, Miño Fugarolas G, Pera Madrazo C.
    Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
    [Abstract] [Full Text] [Related]

  • 2. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
    Barnett SP, Hodul PJ, Creech S, Pickleman J, Arahna GV.
    Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
    Closset J, Journe S, Mboti F, El Nakadi I, Gelin M.
    Hepatogastroenterology; 2008 Mar; 55(86-87):1818-23. PubMed ID: 19102400
    [Abstract] [Full Text] [Related]

  • 4. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ, Meester D, Troisi R, Cathenis K, Lameire N, Hemptinne B.
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA, Jeanmonod P, Schuld J, Moussavian MR, Schilling MK, Kollmar O.
    Dig Surg; 2012 Jun; 29(6):484-91. PubMed ID: 23392293
    [Abstract] [Full Text] [Related]

  • 8. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
    Suc B, Msika S, Piccinini M, Fourtanier G, Hay JM, Flamant Y, Fingerhut A, Fagniez PL, Chipponi J, French Associations for Surgical Research.
    Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
    Dobosz M, Dymecki D, Babicki A, Hać S, Gruca Z, Wajda Z.
    Wiad Lek; 2001 Mar; 54(7-8):380-5. PubMed ID: 11641892
    [Abstract] [Full Text] [Related]

  • 12. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
    Vanounou T, Pratt WB, Callery MP, Vollmer CM.
    J Am Coll Surg; 2007 Oct; 205(4):546-57. PubMed ID: 17903728
    [Abstract] [Full Text] [Related]

  • 13. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
    Graham JA, Johnson LB, Haddad N, Al-Kawas F, Carroll J, Jha R, Wong J, Maglaris D, Mertens S, Fishbein T.
    Am J Surg; 2011 Apr; 201(4):481-5. PubMed ID: 21421102
    [Abstract] [Full Text] [Related]

  • 14. Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial.
    Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, Hyslop T, Schmidt CM, Rosato EL, Lavu H, Nakeeb A, Pitt HA, Lillemoe KD, Yeo CJ.
    J Am Coll Surg; 2009 May; 208(5):738-47; discussion 747-9. PubMed ID: 19476827
    [Abstract] [Full Text] [Related]

  • 15. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis.
    Paran H, Neufeld D, Mayo A, Shwartz I, Singer P, Kaplan O, Skornik Y, Klausner J, Freund U.
    J Am Coll Surg; 1995 Aug; 181(2):121-4. PubMed ID: 7627383
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
    You DD, Paik KY, Park IY, Yoo YK.
    Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic irrigation around a pancreaticojejunostomy for the treatment of a pancreatic fistula after a pancreaticoduodenectomy in patients with a risky pancreatic remnant.
    Nakano H, Asakura T, Sakurai J, Koizumi S, Asano T, Watanabe T, Otsubo T.
    Hepatogastroenterology; 2008 Feb; 55(82-83):717-21. PubMed ID: 18613441
    [Abstract] [Full Text] [Related]

  • 20. [Role octreotide in prevention of complications after pancreatoduodenal resections].
    Shatverian GA, Ratnikova NP, Mikhaĭlov IuE, Bedzhanian AL, Sidorov AN, Fisenko EP, Skipenko OG.
    Khirurgiia (Mosk); 2004 Feb; (2):56-60. PubMed ID: 14997883
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.